We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
The MHRA emphasises the importance of national reporting of any suspected adverse incidents associated with the product following CE certification withdrawal and cease of manufacturing.
Guidance on the cardiovascular safety of Cox-2 inhibitors and NSAIDs and further reading.
Current cardiovascular disease (CVD) prevention is based on diagnosis and treatment of specific disease
An advisory panel working together with the DVLA providing expert advice with the aim of improving road safety.
Proposed changes to the cardiac monitoring unit and acute medical services in Bridlington, North Yorkshire.
These reports explain our assessment of the scientific evidence used to lead to regulatory decisions on the safety of medicines or medicines classes.
This study aims to estimate the costs of Cardiovascular Disease and the costs of Diabetes Mellitus to individuals and society
Calcium salts (either calcium chloride or calcium gluconate) are used to stabilise the myocardium and prevent cardiac arrest in patients experiencing severe hyperkalaemia. However, the two salts are not equivalent in terms of calcium dose. Ensure the correct dose is...
Preventing people in England from developing high blood pressure (hypertension), and detecting and managing it better in those who have it.
Appendix to the assessing fitness to drive guide for medical professionals.
Volume 47 of the non-technical summaries granted under the Animals (Scientific Procedures) Act 1986 during 2013.
Hypertension and diabetes are major risk factors for cardiovascular disease (CVD)
Check if you need to tell DVLA about a health or medical condition, how to report medical conditions to DVLA
How to use a cost effectiveness analysis to evaluate your digital health product.
How to use a cost utility analysis to evaluate your digital health product.
Data and analysis of cardiovascular disease (CVD) prevalence, variation, treatment and outcomes in the Chorley and South Ribble CCG area.
An exploratory study from Zhejiang, China
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).